887592-68-9 Usage
General Description
2-(2-cyano-acetyl)-piperidine-1-carboxylic acid tert-butyl ester is a chemical compound that belongs to the class of piperidine carboxylic acid derivatives. It is a synthetic intermediate used in the pharmaceutical industry for the production of various drugs and active pharmaceutical ingredients. 2-(2-CYANO-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is a tert-butyl ester, which means it contains a tert-butyl functional group. The presence of the cyano-acetyl group and piperidine ring in its structure makes it a versatile building block for the synthesis of complex molecules. It is commonly used in the development of drugs for neurological and psychiatric disorders, as well as for pain management. Due to its diverse applications, 2-(2-cyano-acetyl)-piperidine-1-carboxylic acid tert-butyl ester is an important compound in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 887592-68-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,5,9 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 887592-68:
(8*8)+(7*8)+(6*7)+(5*5)+(4*9)+(3*2)+(2*6)+(1*8)=249
249 % 10 = 9
So 887592-68-9 is a valid CAS Registry Number.
887592-68-9Relevant articles and documents
PIPERIDINE SUBSTITUTED TRICYCLIC PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES WITH INHIBITORY ACTIVITY ON THE REPLICATION OF THE RESPIRATORY SYNCYTIAL VIRUS (RSV)
-
Page/Page column 16; 17; 18, (2016/06/28)
The invention concerns novel substituted tricyclic pyrazolo pyrimidine compounds of formula (I-a) or (I-b) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.
Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach - Part 1
Dwyer, Michael P.,Paruch, Kamil,Labroli, Marc,Alvarez, Carmen,Keertikar, Kerry M.,Poker, Cory,Rossman, Randall,Fischmann, Thierry O.,Duca, Jose S.,Madison, Vincent,Parry, David,Davis, Nicole,Seghezzi, Wolfgang,Wiswell, Derek,Guzi, Timothy J.
scheme or table, p. 471 - 474 (2011/02/26)
The synthesis and hit-to-lead SAR development of a pyrazolo[1,5-a] pyrimidine hit 4 is described leading to a series of potent, selective CHK1 inhibitors such as compound 17r. In the Letter, the further utility of the pyrazolo[1,5-a]pyrimidine template fo
